InsiderDB

SEC EDGAR · Company announcement

NRG: Leadership change · Company disclosure

Filed 8-K for an event or period dated 2026-05-21. Leadership change; Company disclosure.

Follow NRG
Became public
May 21, 2026, 8:10 AM EDT
Event / period date
May 21, 2026
Collected
Nov 10, 2026, 2:22 PM EST

Why this is connected

This filing identifies NRG ENERGY, INC. as the issuer of the security. The company's SEC identifier connects it to NRG.

Press Release, dated May 21, 2026 ↗

Source evidence

Read the source excerpt or record
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On May 21, 2026, upon the recommendation of the Governance and Nominating Committee of NRG Energy, Inc. (the “Company”), the Board of Directors (the “Board”) appointed Glenn Wright to serve as an independent director, effective May 26, 2026, until his successor is duly elected and qualified or until his earlier death, resignation or removal. Dr. Wright was also appointed to serve on the Finance and Risk Management Committee of the Board. There is no arrangement or understanding between Dr. Wright and any other person, other than the Company, pursuant to which he was appointed as a director. Dr. Wright has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. Dr. Wright, age 60, most recently served as Senior Vice President, Shell Energy Americas, and President and Chief Executive Officer, Shell New Energies, US from 2020 to 2025. Prior to that, from 2016 to 2020, Dr. Wright served as Vice President, Shell Energy Trading Americas, and President and Chief Executive Officer, Shell Energy North America. From 2005 to 2016, he held various leadership positions at Shell in roles spanning power and gas trading and business development. Dr. Wright currently serves on the board of Hydrostor Inc., a private energy storage company based in Canada. Dr. Wright received a B.S. in chemical engineering from the Georgia Institute of Technology, and an M.S., Ph.D. and M.B.A. from The University of Texas at Austin. Dr. Wright will participate in the Company’s director compensation program, as described in the Company’s 2026 Proxy Statement, filed with the SEC on Ma

Congressional trading in NRG

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.